153 research outputs found

    Safety and in vivo immune assessment of escalating doses of oral laquinimod in patients with RRMS

    Get PDF
    Background Laquinimod is an oral immunomodulator in clinical development to treat relapsing-remitting multiple sclerosis (RRMS). Laquinimod is in clinical development for the treatment of multiple sclerosis and Huntington Disease (HD). The objective of this study is to assess the safety, tolerability, pharmacokinetics (PK) and cytoimmunologic effects following escalating doses of laquinimod in patients with RRMS. Methods One hundred twelve patients were randomly assigned to laquinimod/placebo in a series of separate dose- escalating cohorts starting from a daily oral dose of 0.9 mg/1.2 mg escalating to 2.7 mg, in 0.3 mg increments. Results Twenty-eight patients received placebo and 84 received laquinimod ranging from 0.9 to 2.7 mg. No deaths occurred. One serious adverse event (SAE) of perichondritis was reported, which was unrelated to laquinimod (0.9 mg). There was no increased incidence of adverse events (AEs) with escalating doses. Laquinimod-treated patients showed more abnormal laboratory levels in liver enzymes, P-amylase, C-reactive protein (CRP), and fibrinogen, but most shifts were clinically non- significant. The exposure of laquinimod was dose proportional and linear in the tested dose range. An immunological substudy showed significant dose- dependent decreases in 6-sulpho LacNAc + dendritic cell (slanDC) frequency following laquinimod compared to placebo. Conclusion Laquinimod doses up to 2.7 mg were safely administered to patients with RRMS. An in vivo effect of laquinimod on the innate immune system was demonstrated. Trial registration EudraCT Number: 2009-011234-99. Registered 23 June 2009

    Auxin Inhibition of Flower Induction of Pharbitis

    Full text link

    Flowering Response of Pharbitis nil

    Full text link

    Let your students speak: fun and effective ways to increase studentsā€™ confidence to speak

    Get PDF
    In the communicative model of language teaching, we should help our students develop authentic practice for real-life communication situations since the main goal of English Language Teaching is to empower students to become independent learners. In order to do this, multi-sensory tasks requiring integrated skills should be offered to students. The teachersā€™ feedback reveals that creating real-life communication situations can enrich and foster in-class speaking and prevent students from misunderstandings and communication breakdowns. Drawings, headlines, diagrams and cards are excellent sources to make lessons more memorable and enjoyable.The main purpose of this presentation is to introduce a series of innovative and creative activities increasing studentsā€™ motivation and confidence to speak more voluntarily inside and outside class

    Folateā€targeted nanoparticles show efficacy in the treatment of inflammatory arthritis

    Full text link
    Objective To investigate the uptake of a poly(amidoamine) dendrimer (generation 5 [G5]) nanoparticle covalently conjugated to polyvalent folic acid (FA) as the targeting ligand into macrophages, and to investigate the activity of an FAā€ and methotrexate (MTX)ā€“conjugated dendrimer (G5ā€FAā€MTX) as a therapeutic for the inflammatory disease of arthritis. Methods In vitro studies were performed in macrophage cell lines and in isolated mouse macrophages to check the cellular uptake of fluorescenceā€tagged G5ā€FA nanoparticles, using flow cytometry and confocal microscopy. In vivo studies were conducted in a rat model of collagenā€induced arthritis to evaluate the therapeutic potential of G5ā€FAā€MTX. Results Folateā€targeted dendrimer bound and internalized in a receptorā€specific manner into both folate receptor Ī²ā€“expressing macrophage cell lines and primary mouse macrophages. The conjugate G5ā€FAā€MTX acted as a potent antiinflammatory agent and reduced arthritisā€induced parameters of inflammation such as ankle swelling, paw volume, cartilage damage, bone resorption, and body weight decrease. Conclusion The use of folateā€targeted nanoparticles to specifically target MTX into macrophages may provide an effective clinical approach for antiinflammatory therapy in rheumatoid arthritis.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/86938/1/30459_ftp.pd

    The Genetic Background of the Curly Tail Strain Confers Susceptibility to Folate-Deficiency-Induced Exencephaly

    Get PDF
    BACKGROUND: Suboptimal maternal folate status is considered a risk factor for neural tube defects (NTDs). However, the relationship between dietary folate status and risk of NTDs appears complex, as experimentally induced folate deficiency is insufficient to cause NTDs in nonmutant mice. In contrast, folate deficiency can exacerbate the effect of an NTD-causing mutation, as in splotch mice. The purpose of the present study was to determine whether folate deficiency can induce NTDs in mice with a permissive genetic background which do not normally exhibit defects. METHODS: Folate deficiency was induced in curly tail and genetically matched wild-type mice, and we analyzed the effect on maternal folate status, embryonic growth and development, and frequency of NTDs. RESULTS: Folate-deficient diets resulted in reduced maternal blood folate, elevated homocysteine, and a diminished embryonic folate content. Folate deficiency had a deleterious effect on reproductive success, resulting in smaller litter sizes and an increased rate of resorption. Notably, folate deficiency caused a similar-sized, statistically significant increase in the frequency of cranial NTDs among both curly tail (Grhl3 mutant) embryos and background-matched embryos that are wild type for Grhl3. The latter do not exhibit NTDs under normal dietary conditions. Maternal supplementation with myo-inositol reduced the incidence of NTDs in the folate-deficient wild-type strain. CONCLUSIONS: Dietary folate deficiency can induce cranial NTDs in nonmutant mice with a permissive genetic background, a situation that likely parallels gene-nutrient interactions in human NTDs. Our findings suggest that inositol supplementation may ameliorate NTDs resulting from insufficient dietary folate. Birth Defects Research (Part A), 2010. Ā© 2009 Wiley-Liss, Inc
    • ā€¦
    corecore